Angelo D. Palmas

Nuoro, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Increased risk of secondary malignancies after autologous transplantation in R/R follicular lymphoma: Long-term results from FIL-FLAZ12 Phase III trial.

Increased risk of secondary malignancies after autologous transplantation in R/R follicular lymphoma: Long-term results from FIL-FLAZ12 Phase III trial.

Journal: HemaSphere
Published: April 02, 2026

Occupational exposure to formaldehyde and risk of lymphoma subtypes: results of a multicentre Italian case-control study.

Occupational exposure to formaldehyde and risk of lymphoma subtypes: results of a multicentre Italian case-control study.

Journal: Environmental health : a global access science source
Published: July 17, 2025

Early Diagnosis of Gaucher Disease and ASMD in Sardinia: The "Ichnos" Project.

Early Diagnosis of Gaucher Disease and ASMD in Sardinia: The "Ichnos" Project.

Journal: Mediterranean journal of hematology and infectious diseases
Published: June 01, 2025

Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub-Study of the FOLL12 Trial.

Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub-Study of the FOLL12 Trial.

Journal: American journal of hematology
Published: December 09, 2024

Large clones of clonal hematopoiesis affect outcome in mantle cell lymphoma: results from the FIL MCL0208 clinical trial.

Large clones of clonal hematopoiesis affect outcome in mantle cell lymphoma: results from the FIL MCL0208 clinical trial.

Journal: Blood advances
Published: September 30, 2024

The impact of insularity on SARS-CoV-2 diffusion: Recapitulating three years of COVID-19 pandemic in the island of Sardinia.

The impact of insularity on SARS-CoV-2 diffusion: Recapitulating three years of COVID-19 pandemic in the island of Sardinia.

Journal: Journal of infection and public health
Published: February 22, 2024

Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma.

Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma.

Journal: Blood
Published: August 03, 2023

Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial.

Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial.

Journal: The Lancet. Oncology
Published: August 06, 2022

Molecular Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 Isolates From Central Inner Sardinia.

Molecular Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 Isolates From Central Inner Sardinia.

Journal: Frontiers in microbiology
Published: December 02, 2021

Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial.

Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial.

Journal: The Lancet. Oncology
Published: June 22, 2021

Early Diffusion of SARS-CoV-2 Infection in the Inner Area of the Italian Sardinia Island.

Early Diffusion of SARS-CoV-2 Infection in the Inner Area of the Italian Sardinia Island.

Journal: Frontiers in microbiology
Published: November 11, 2020

Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.

Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.

Journal: The Lancet. Haematology
Published: January 29, 2020
Showing 1-12 of 21

Last Updated: 09/26/2026